The Journal of Clinical Virology Plus, published by Elsevier, is an essential resource for researchers and professionals in the fields of virology and infectious diseases. Launched in 2021, this journal aims to bridge the gap between clinical research and application, fostering a deeper understanding of viral pathogenesis, diagnostics, and therapeutic strategies. With an ISSN of 2667-0380, this open-access journal brings cutting-edge findings to the global scientific community, facilitating the rapid dissemination of knowledge critical for advancing public health. Positioned in the Q3 category for both Infectious Diseases and Virology in 2023, its ranking reflects its growing influence and relevance in the academic landscape. The journal strives to support innovative research, collaborative studies, and comprehensive reviews that address contemporary challenges in clinical virology. As it converges through the years from 2021 to 2024, Journal of Clinical Virology Plus aims to be a central hub for vital discussions and breakthroughs in this dynamic field.

BMC Infectious Diseases is a premier open-access journal published by BMC in the United Kingdom, dedicated to the field of infectious diseases. Established in 2001, this journal has been at the forefront of disseminating high-quality, peer-reviewed research, contributing significantly to the global understanding of infectious pathogens and their impact on public health. With a 2023 Scopus ranking of #100 out of 344 in the Medicine - Infectious Diseases category, and a notable Q1 quartile classification, it stands as a vital resource for researchers and professionals alike. Authors benefit from the journal's broad reach and visibility, ensuring their work is accessible to a wide audience. Access options are fully open, allowing for seamless dissemination of knowledge in the ongoing battle against infectious diseases. With an established history of publishing groundbreaking studies, BMC Infectious Diseases plays a crucial role in addressing critical issues and advancing research in the ever-evolving landscape of infectious diseases.

Infectious Diseases and Therapy is a premier scholarly journal published by Springer London Ltd, dedicated to advancing the understanding of infectious diseases through rigorous research and evidence-based therapy. With an esteemed Q1 ranking in both the Infectious Diseases and Microbiology (medical) categories, this journal is a vital resource for researchers, healthcare professionals, and students aiming to stay at the forefront of developments within the field. Launched in 2012, it has embraced an Open Access model, ensuring that groundbreaking studies and critical reviews are accessible to a global audience. Operating from its office in London, the journal encourages the dissemination of innovative therapies and diagnostic methods, fostering collaboration and knowledge sharing among the scientific community. In a landscape where infectious diseases pose significant health challenges, Infectious Diseases and Therapy stands as an essential platform for impactful research that can lead to improved healthcare outcomes worldwide.

Current Treatment Options in Infectious Diseases, published by SpringerNature, is a pivotal peer-reviewed journal dedicated to advancing the field of infectious disease management and therapy. With a focus on the latest treatment modalities, this journal serves as a vital resource for researchers, healthcare professionals, and students striving to improve patient outcomes in infectious diseases. Although it is not an open-access journal, it offers valuable insights through carefully curated articles that emphasize evidence-based practices and innovative approaches in the treatment landscape. By fostering a cross-disciplinary dialogue, Current Treatment Options in Infectious Diseases aims to bridge the gap between research and clinical application, making it an essential platform for staying abreast of developments in this rapidly evolving field.

PREVENTIVE VETERINARY MEDICINE, published by Elsevier, is a premier academic journal dedicated to advancing the field of veterinary science, with a particular focus on the prevention of diseases in food animals. With an impressive impact factor that reflects its stature in the academic community, this journal is categorized in the Q1 quartile across both Animal Science and Zoology and Food Animals categories, underscoring its significance in agricultural and biological sciences. Established in 1982, the journal is known for its rigorous peer-reviewed articles and research insights that contribute significantly to veterinary epidemiology, herd health management, and disease prevention strategies, fostering a closer connection between veterinary practitioners and researchers. By offering a platform for high-quality research that enhances animal health and productivity, PREVENTIVE VETERINARY MEDICINE serves as an essential resource for researchers, veterinarians, and students aiming to stay at the forefront of veterinary innovations and practices.

Emerging Infectious Diseases, published by the Centers for Disease Control and Prevention, is a leading open-access journal that has been dedicated to the field of epidemiology, infectious diseases, and medical microbiology since its inception in 1995. With an impressive impact factor placing it in the Q1 quartile rankings for multiple categories including Epidemiology, Infectious Diseases, and Medical Microbiology, this journal serves as a vital resource for researchers, practitioners, and students dedicated to combating the challenges posed by emerging infectious diseases. The journal's distinguished Scopus ranks further highlight its global influence, ranking #10 in Epidemiology, #26 in Infectious Diseases, and #13 in Medical Microbiology, all within the top percentiles. Accessible and targeted, Emerging Infectious Diseases publishes seminal research and reviews that contribute to the understanding and management of infectious diseases, ensuring that critical insights reach a broad audience. The journal encourages contributions that advance the scientific community’s knowledge and responses to public health challenges.

Infectious Disease Reports is a premier open-access journal published by MDPI, dedicated to advancing the field of infectious diseases. Since its inception in 2009, this journal has established itself as a significant platform for disseminating cutting-edge research, reviews, and case studies, critical for global health. With a commendable Q2 ranking in the category of Infectious Diseases and a Scopus rank of #140 out of 344, it is recognized for its impactful contributions to medical research, holding a 59th percentile in its field. The journal aims to provide comprehensive insights into various dimensions of infectious diseases, ranging from epidemiology to novel treatment modalities. As an open-access publication, Infectious Disease Reports ensures that its articles are freely available to a wide audience, fostering collaborative efforts among researchers, healthcare professionals, and students worldwide. With its ongoing commitment to excellence, the journal plays an essential role in shaping the future of infectious disease research.

INFECTION is a prestigious journal, published by Springer Heidelberg, that serves as a leading platform for the dissemination of critical research in the fields of Infectious Diseases, Microbiology, and Medicine. With an impressive Q1 ranking in multiple categories such as Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, the journal is recognized for its high-quality content and impactful contributions to the scientific community, as evidenced by its Scopus rankings placing it in the top 10th percentiles. Since its inception in 1973, and projected to continue until 2024, INFECTION has established itself as a vital resource for researchers, healthcare professionals, and students keen to explore the latest findings and advancements in infectious diseases. The journal provides a rigorous peer-review process, ensuring that only high-quality studies are published, making it an essential read for those seeking to deepen their understanding and stay abreast of the rapidly evolving landscape in infection research.

Welcome to Transboundary and Emerging Diseases, a prestigious journal published by WILEY-HINDAWI. With its ISSN of 1865-1674 and E-ISSN of 1865-1682, this journal plays a pivotal role in the dissemination of high-quality research within the fields of Immunology, Microbiology, Medicine, and Veterinary Sciences. Based in the United Kingdom, this open-access journal stands out with a remarkable impact factor, reflecting its category quartiles in 2023, where it secured Q1 rankings across multiple disciplines, including a remarkable rank of #3 out of 194 in Veterinary General, placing it in the top 2% of its field. With coverage spanning from 2008 to 2024, Transboundary and Emerging Diseases provides a vital platform for researchers, professionals, and students to explore emerging threats to global health and animal welfare. The journal's commitment to open access ensures broad availability of cutting-edge research, fostering collaboration and knowledge sharing in pursuit of innovative solutions to transboundary diseases. Join a community dedicated to advancing the science and practice within this crucial area of study.

PLoS Computational Biology is a premier open-access journal published by the Public Library of Science, committed to advancing the understanding of complex biological data through computational approaches. Since its inception in 2005, the journal has made significant strides in the fields of Cellular and Molecular Neuroscience, Computational Theory and Mathematics, Ecology, Genetics, and Molecular Biology, achieving a notable Q1 ranking in various categories as of 2023. With an exceptional impact factor and an esteemed ranking—such as Rank #23/176 in Computational Theory and Mathematics—PLoS Computational Biology provides a vital platform for researchers, professionals, and students to disseminate their cutting-edge findings and insights. The journal's open-access model ensures that high-quality research is freely accessible worldwide, fostering collaboration and innovation across disciplines. Located in San Francisco, CA, it serves as a hub for the global scientific community, making it an indispensable resource for anyone at the forefront of computational biology and its diverse applications.